Berberine exerts an anticonvulsant effect and ameliorates memory impairment and oxidative stress in a pilocarpine-induced epilepsy model in&nbsp;the rat by Gao F et al.
© 2014 Gao et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0)  
License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further 
permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on 
how to request permission may be found at: http://www.dovepress.com/permissions.php
Neuropsychiatric Disease and Treatment 2014:10 2139–2145
Neuropsychiatric Disease and Treatment Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
2139
OrigiNal research
open access to scientific and medical research
Open access Full Text article
http://dx.doi.org/10.2147/NDT.S73210
Berberine exerts an anticonvulsant effect and 
ameliorates memory impairment and oxidative 
stress in a pilocarpine-induced epilepsy model 
in the rat
Fei gao1,*
Ying gao2,*
Yang-feng liu3
li Wang4
Ya-jun li1
1Department of Neurology, First 
affiliated hospital of Xi’an Medical 
University, Xi’an, People’s republic of 
china; 2Department of radiotherapy 
Oncology, First affiliated hospital 
of Medical college of Xi’an Jiaotong 
University, Xi’an, People’s republic 
of china; 3Department of Neurology, 
People’s liberation army No. 451 
hospital, Xi’an, People’s republic 
of china; 4Department of scientific 
research, First affiliated hospital 
of Xi’an Medical University, Xi’an, 
People’s republic of china
*These authors contributed equally 
to this work
Abstract: Though new antiepileptic drugs are emerging, approximately a third of epileptic 
patients still suffer from recurrent convulsions and cognitive dysfunction. Therefore, we tested 
whether berberine (Ber), a vegetable drug, has an anticonvulsant property and attenuates memory 
impairment in a pilocarpine (Pilo)-induced epilepsy model in rats. The rats were injected with 
400 mg/kg Pilo to induce convulsions, and Ber 25, 50, and 100 mg/kg were administrated by 
the intragastric route once daily 7 days before Pilo injection until the experiment was over. 
Convulsions were observed after Pilo injection. For the rats that developed status epilepticus 
(SE), malondialdehyde, glutathione levels, superoxide dismutase, and catalase activity in the 
hippocampus were measured 24 hours after SE. The rats received the Morris water-maze test 
2 weeks after SE, and then were killed for fluoro-jade B staining to detect the degenerating 
neurons. We found Ber delayed latency to the first seizure and the time to develop SE in a 
dose-dependent manner. Malondialdehyde levels were decreased, while glutathione and catalase 
activity were strengthened in Ber-injected SE rats. In the Morris water-maze test, Ber decreased 
escape latency compared to saline-treated SE rats. Additionally, Ber reduced the number of 
fluoro-jade B-positive cells in the hippocampal CA1 region. Our data suggest that Ber exerts 
anticonvulsant and neuroprotective effects on Pilo-induced epilepsy in rats. Simultaneously, 
Ber attenuates memory impairment. The beneficial effect may be partly due to mitigation of 
the oxidative stress burden.
Keywords: status epilepticus, pilocarpine, memory impairment, oxidative stress, 
neuroprotection
Introduction
Epilepsy, a neurological disorder characterized by recurrent episodes of seizures due 
to an imbalance between cerebral excitability and inhibition, affects approximately 
50 million people worldwide.1 Seizures in 20%–30% epileptic patients cannot be 
controlled effectively, though new antiepilepsy drugs (AEDs) are growing in number.   
A large number of patients suffer from cognitive dysfunction.2–4 The present AEDs 
can only ameliorate the occurrence of seizures, while they are not helpful for cognitive 
dysfunction. Moreover, cognitive impairment is one of the side effects of AEDs.5 There-
fore, the need for newer and more efficacious AEDs is urgent.
The epilepsy model induced by pilocarpine (Pilo), a potent muscarinic cholinergic 
agonist, is a useful animal model to reproduce behavioral and electroencephalographic 
alterations similar to those in human epilepsy.6 The brain processes large amounts 
of O2 in a relatively small mass, and has a high content of substrates available for 
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oxidation associated with low antioxidant activities, mak-
ing it extremely susceptible to oxidative damage.7 Under 
normal conditions, there is a steady-state balance between 
the production of reactive oxygen species and their destruc-
tion by antioxidant systems. However, in the Pilo epilepsy 
model, this balance has been broken by increased reactive 
oxygen species production or/and by a decrease in cellular 
antioxidant systems, such as catalase (CAT) and superoxide 
dismutase (SOD). This imbalance contributes to irrevers-
ible neuronal damage of cell-membrane phospholipid, and 
it has been suggested as a possible mechanism of epileptic 
activity.8 Previous studies have suggested that antioxidative 
therapy may have beneficial effects on epilepsy.9,10
Berberine (Ber) is the major active constituent of Rhizoma 
coptidis and other plants, and has multiple pharmacological 
effects, including anticholinergic, antihypotensive, antiar-
rhythmic, antiosteoporotic, cardioprotective, antitumor and 
antimalarial effects.11 In central nervous system diseases, 
such as cerebral ischemia, Ber has neuroprotective function 
through its anti-inflammatory, antioxidative and antineu-
ronal apoptosis pharmacological properties.12–14 Recent 
research has indicated that Ber has an anticonvulsant effect 
on a pentylenetetrazol–maximal electroshock–kainic acid-
induced epileptic model in mice.15 However, the underlying 
mechanism remains unknown.
The present study was therefore designed to evaluate anti-
convulsant activity of Ber in Pilo-induced status epilepticus 
(SE) rats. We also evaluated the effects of Ber on oxidative 
stress, memory impairment, and neuronal degeneration in 
this process.
Materials and methods
animals and experimental procedures
Male Sprague Dawley rats, weighing between 220 and 250 g 
were used in this study. The rats were housed in a controlled 
environment (21°C±1°C and 60% humidity, under a 12-hour 
light/dark cycle, lights on at 8 am). Food and water were 
available ad libitum. All animal procedures were carried out 
in accordance with the National Institutes of Health Guide 
for the Care and Use of Laboratory Animals.
The rats were randomly divided into six groups in this 
experiment: 1) control group (n=12), administered saline 
alone; 2) Ber 100 group (n=12), administered Ber (100 mg/kg)   
alone; 3) Pilo group (n=20), administered Pilo; 4) Pilo + Ber 
25 group (n=20), administered both Ber (25 mg/kg) and Pilo; 
5) Pilo + Ber 50 group (n=20), administered both Ber (50 mg/
kg) and Pilo; 6) Pilo + Ber 100 group (n=20), administered 
with both Ber (100 mg/kg) and Pilo.
Ber was dissolved in 0.9% saline and administered by 
intragastric route once daily for 7 days before Pilo injection 
until the experiment was over. In the control group, equiva-
lent saline was administered instead of Ber. All rats received 
methylscopolamine (1 mg/kg, intraperitoneally) 45 minutes 
before Pilo injection to minimize the peripheral effects of 
Pilo. Rats were continuously monitored to detect any behav-
iors indicative of seizure activity for 120 minutes following 
Pilo administration. Epileptic activity was graded according 
to the Racine scale.16 An animal was considered to be in SE 
when continuous generalized seizure activity was observed 
without normal behavior in seizure episodes.17 When rats 
had experienced SE for 1 hour, seizures were terminated 
by intraperitoneal injection of 10 mg/kg diazepam. All SE 
animals were given water-soaked food until they were able 
to eat normal dry-food pellets.
At 24 hours after SE, rats were killed for the valuation 
of lipid peroxidation, GSH, SOD, and CAT activity. The 
surviving SE rats received the Morris water maze (MWM) 
test 14 days after SE, and were killed for fluoro-jade B (FJB) 
stains after the MWM test.
Drugs and chemicals
All drugs were purchased from Sigma (St Louis, MO, USA). 
MDA, GSH, SOD, and CAT activity assay kits were pur-
chased from Jiancheng Bioengineering Institute (Nanjing, 
People’s Republic of China).
Tissue preparation
The animals were deeply anesthetized (10% chloral hydrate, 
350 mg/kg, intraperitoneally) and killed by decapitation. 
Their brains were rapidly dissected on ice to remove the hip-
pocampus for determination of MDA, GSH, SOD, and CAT 
activities. The brain samples were weighed and kept at -70°C 
until analyzed. Each brain sample was then homogenized in 
5% w/v 20 mM phosphate buffer, pH 7.4.
For the FJB stain, rats were deeply anesthetized and 
perfused transcardially with 0.9% saline (100 mL), followed 
by 4% paraformaldehyde (200 mL). Brains were removed 
and postfixed overnight in 4% paraformaldehyde, and then 
in a 30% sucrose solution at 4°C. When brains sank to the 
bottom of the solution, serial coronal sections (30 μm thick-
ness) were made through the entire hippocampus using a 
sliding microtome.
lipid peroxidation level
According to a previous experiment,18 lipid peroxidation 
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reactive species. This is expressed as nanomoles of MDA/g 
wet tissue.
catalase activity
This was assessed according to the methods of Aebi,19 in 
which the CAT reaction is stopped after 1 minute with a CAT 
inhibitor. This is expressed as mmol/min/mg protein.
superoxide dismutase activity
As described by Misra and Fridovich,20 SOD activity is 
expressed as U/mg protein.
reduced glutathione level
GSH level was assayed spectrophotometrically as described 
by Beutler et al21 and is expressed as nmol/mg protein.
FJB staining
FJB staining of brain slices was carried out to identify 
neurons undergoing degeneration.22 Floating sections were 
mounted on slides and dried at room temperature. Sections 
were then rehydrated by sequential soaking in 100% ethanol 
(5 minutes), 70% ethanol (2 minutes), and distilled water 
(2 minutes). After 15 minutes, sections were incubated in 
0.06% potassium permanganate and rinsed for 1 minute 
in distilled water, then immersed in a solution containing 
0.0004% FJB and 0.1% acetic acid for 30 minutes. After 
washing, the sections were coverslipped. The number of FJB 
positive neuronal cells was calculated in per millimeter length 
of the hippocampal CA1 pyramidal cell layer.
Morris water-maze test
The MWM test is widely used for assessment of spatial 
memory. A test pool (diameter 140 cm, 60 cm deep) was filled 
with water (water temperature 22°C±1°C) made opaque by the 
addition of a white nontoxic paint. A platform (10×10 cm) was 
placed 1.5 cm below the surface of the water. The rats were 
placed into the pool at four different starting points. Then, rats 
were tested for their ability to locate the hidden platform. Rats 
were given two trials per day, and a trial ended when the rat 
escaped onto the platform. The escape latency for each trial 
was recorded. Each trial was started and ended manually by 
the experimenter. The movement of the rats was monitored 
by a digital camera (HVR-S270C; Sony, Tokyo, Japan).
statistical analysis
All measurement data are expressed as means ± standard 
error of mean. One-way analysis of variance (ANOVA) 
followed by the least significant difference post hoc test 
was used for the analysis of FJB stain and oxidative stress 
study data. Two-way repeated-measure ANOVA was used to 
analyze data in the MWM test. For the analysis of categorical 
data, Fisher’s exact test was used. P0.05 was considered 
statistically significant.
Results
Berberine relieved pilocarpine-induced 
convulsions in rats
After Pilo injection, all rats inhibited convulsive behaviors, 
such as head bobbing, scratching, and chewing. In the 
Pilo group, the first episode of seizures occurred at 
16.7±2.37 minutes. However, 25 mg/kg Ber treatment 
significantly delayed latency to first seizure (P0.05). In the 
50 mg/kg and 100 mg/kg Ber groups, latency to first seizure 
was 33.8±2.75 min and 45.2±2.70 min, respectively. Com-
pared to the Pilo group rats, latency was significantly longer 
(P0.01). Time to SE in the Pilo + Ber 25 group rats was 
delayed significantly compared with that in the Pilo group rats 
(P0.05). After Ber 50 mg/kg and Ber 100 mg/kg injection, 
time to SE increased to 40.8±3.13 and 50.5±3.34 minutes, 
respectively. They both increased significantly compared 
with that in the Pilo group. Rats in the control and Ber 
100 groups showed no seizures in the 2 hours after saline or 
Ber injection. Nineteen of 20 rats developed SE and nine rats 
died in the Pilo group, while 14 of 20 rats developed SE and 
three rats died in the Pilo + Ber 50 group. The percentage SE 
between the two groups was significantly different (P0.05). 
The incidence of SE also significantly decreased in the Pilo + 
Ber 100 group compared to that in the Pilo group (P0.01). 
Percentage survival in Ber 100 mg/kg-treated SE rats was 
90%. The experimental data are shown in Table 1.
Berberine decreased the degree 
of oxidative stress in the hippocampus 
24 hours after pilocarpine-induced 
se in rats
At 24 hours after SE, the CAT level of hippocampus signifi-
cantly increased in Pilo-group rats compared to saline-treated 
control rats (P0.01, four to six rats per group, Figure 1A). In 
the Ber 50 and Ber 100 groups, hippocampal CAT levels were 
significantly higher than in the saline-treated SE rats (P0.01, 
four to six rats per group, Figure 1A). There was a significant 
fall in GSH levels in hippocampal tissue of SE rats compared 
to saline-treated control rats (P0.01, four to six rats per group, 
Figure 1B). In the Ber 25 group, GSH levels in the hippocampus 
significantly increased compared with saline-treated SE rats Neuropsychiatric Disease and Treatment 2014:10 submit your manuscript | www.dovepress.com
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(P0.05, four to six rats per group, Figure 1B). With increased 
Ber dose, there were significantly growing GSH levels of hip-
pocampal tissue in the 50 and 100 mg/kg Ber treatment groups 
(both P0.01, four to six rats per group, Figure 1B). The effects 
of administration of Ber on lipid peroxidation are depicted in 
Figure 1C. Compared with saline-treated control rats, there 
was a significant rise in MDA levels in the hippocampus in SE 
rats. Ber (25, 50 and 100 mg/kg) significantly reduced MDA 
levels in the hippocampus compared to SE rats in the Pilo group 
(P0.05, P0.01, and P0.01, respectively, four to six rats per 
group, Figure 1C). As in our previous study,23 the SOD level 
in hippocampus showed no significant change between SE rats 
Table 1 effects of berberine on pilocarpine-induced convulsions in rats
Groups Latency to first  
seizure (minutes)
Time to SE  
(minutes)
Percentage SE Percentage survival   
in SE rats
control Ns Ns Ns Ns
Pilo 16.7±2.37 29.3±2.40 95% (19 of 20) 53% (10 of 19)
Pilo + Ber 25 28.4±3.01* 37.5±2.62* 85% (17 of 20) 53% (9 of 17)
Pilo + Ber 50 33.8±2.75** 40.8±3.13** 70% (14 of 20)* 79% (11 of 14)
Pilo + Ber 100 45.2±2.70** 50.5±3.34** 50% (10 of 20)** 90% (9 of 10)
Ber 100 Ns Ns Ns Ns
Notes: results are expressed as means ± standard error of the mean (seM).*P0.05 compared to the Pilo group; **P0.01 compared to the Pilo group.
Abbreviations: Ns, no seizures; se, status epilepticus; Pilo, pilocarpine; Ber, berberine.
Figure 1 effects of berberine (Ber) on catalase (A), glutathione level (B), lipid peroxidation level (C), and superoxide dismutase (D) activities in hippocampus 24 hours after 
Pilo-induced status epilepticus in rats (n=4–6 in each group). results are expressed as means ± standard error of mean.
Notes: *P0.05 compared to Pilo group; **P0.01 compared to Pilo group; ##P0.01 compared to control group.
Abbreviations: MDa, malondialdehyde; Pilo, pilocarpine; Ber 25, berberine 25 mg/kg; Ber 50, berberine 50 mg/kg; Ber 100, berberine 100 mg/kg.
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and saline-treated control rats. Three doses of Ber injection had 
no effect on SOD level (all P0.05, four to six rats per group, 
Figure 1D). Ber 100 mg/kg per se did not influence MDA, 
CAT, SOD, or GSH levels.
Berberine prevented memory 
impairment 2 weeks after pilocarpine-
induced se in rats
The mean escape latency for the trained rats decreased over the 
course of the learning trials in all the groups. Two-way repeat-
measure ANOVA revealed that Ber (50 and 100 mg/kg)   
significantly decreased escape latency in SE rats compared 
to saline-treated SE rats (P0.05 and P0.01, respectively, 
five rats per group). However, Ber 25 mg/kg had no effect on 
escape latency. There was no significant difference in escape 
latency between saline-treated control rats and Ber 100 mg/kg 
alone-treated rats (P0.05, five rats per group, Figure 2).
Berberine alleviated the number of FJB-
positive cells in hippocampal ca1 20 days 
after pilocarpine-induced se in rats
At 20 days after SE, no FJB-positive cells (degenerating 
neurons) were detected in hippocampus CA1 in control 
rats or Ber 100 mg/kg alone-treated rats. Abundant FJB-
positive cells were observed in CA1 of saline-treated SE rats   
(Figure 3A). Compared with the saline-treated SE rats, the Ber 
100 mg/kg-treated SE rats had significantly lower amounts of 
FJB-positive cells in CA1 (P0.01, five rats per group, Figure 
3D). The other two Ber dosages also decreased the FJB-positive 
cells in CA1 compared to the saline-treated SE rats (Ber 50 ver-
sus Pilo group, P0.01; Ber 25 versus Pilo group, P0.05; 
respectively; five rats per group, Figure 3B and C).
Discussion
In this study, our data suggested that Ber exerts dose-dependent 
anticonvulsive activity in a Pilo-induced epilepsy model in rats. 
Simultaneously, Ber reduced the degree of oxidative stress 
in the hippocampus, and alleviated neuronal degeneration in 
hippocampal CA1 region in SE rats. Memory impairment in 
SE rats was also reduced by the administration of Ber.
Ber 25, 50, and 100 mg/kg all performed an anticonvul-
sant function. They delayed the onset of first seizure, and 
Figure 2 effects of berberine (Ber) on latency to escape in Morris water-maze 
test 14 days after pilocarpine (Pilo)-induced status epilepticus (se) in rats. Two-
way  repeat-measure  analysis  of  variance  revealed  that  Ber  (50  and  100  mg/kg) 
significantly decreased escape latency in SE rats compared to saline-treated SE rats 
(P0.05 and P0.01, respectively; n=5 in each group). results are expressed as 
means ± standard error of mean.
Notes: *P0.05 compared to Pilo group; **P0.01 compared to Pilo group.
Abbreviations: Ber 25, berberine 25 mg/kg; Ber 50, berberine 50 mg/kg; Ber 100, 
berberine 100 mg/kg; se, status epilepticus.
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reduced time to SE. Ber 100 mg/kg decreased the numbers 
of rats developing SE and the mortality of SE rats. This result 
was similar to a previous study.15 The dosage of Ber used in 
the previous study was much lower than that in our experi-
ment. In our preliminary dosage studies, low dosage, such 
as 10 mg/kg, had no effects on the seizure activity (data not 
shown). This may be attributed to differences in experimental 
animals, epileptic model, and pathway of administration.
Oxidative stress, an imbalance between prooxidants and 
antioxidants, has been indicated to play an important role in 
the pathogenesis of seizures.8 Abnormal values of oxidants 
and antioxidant enzymes are detected in the blood of chil-
dren with refractory epilepsy.24 Reactive oxygen species 
have been implicated in the development of seizures and SE 
induced by Pilo.25,26 In our study, there was an increase in 
lipid peroxidation in the hippocampus of rats 24 hours after 
SE, which was in line with previous studies.23,25 The increased 
lipid peroxidation may do harm to the protein, lipids, and 
deoxyribonucleic acid in the brain.27 It may account for 
the underlying mechanisms for the deficits in cognitive 
function.28 Our data indicated that Ber can markedly prevent 
the rise in brain-lipid peroxidation demonstrated by decreased 
MDA level. It suggested that Ber had antioxidative potential 
in a Pilo-induced SE model in rats, and this pharmacological 
property may be dose-dependent.
CAT and SOD are important antioxidative enzymes 
in the brain. They can protect neuronal cells through the 
removal of free radicals. At 24 hours after SE, the level of 
CAT significantly increased in the hippocampus, in contrast 
to the control rats. This result is consistent with previous 
studies.23,25 The increase in CAT activity may be a compen-
satory mechanism accompanied by an immediate increase 
in free radicals.29 However, the activity of SOD remained 
unaltered at 24 hours after SE. Ber treatment had no effect 
on level of SOD, which suggested Ber cannot strengthen 
SOD activity in this condition.
GSH is another important antioxidant agent in the brain. 
In the present study, Pilo-induced SE decreased the GSH 
level in the rat hippocampus, which damaged the antioxidant 
defense system and may partially have been responsible 
for seizures and neuronal degeneration. Freitas et al also 
observed that hippocampal GSH contents were decreased 
24 hours after SE.25 Ber significantly increased GSH levels 
in a dose-dependent manner compared with Pilo-induced 
SE rats. This demonstrated that Ber may strengthen hip-
pocampal antioxidative ability through increasing the level 
of CAT and GSH, but not SOD, at this time point in Pilo-
induced SE rats.
Cognitive impairment is frequently observed in epileptic 
patients. Though the underlying mechanisms are not well 
known, growing evidence indicates that oxidative stress is one 
of the important causes leading to memory impairment after 
SE.30 Oxidative damage to the rat synapse in the hippocampus 
has been previously reported to contribute to the deficit of 
cognitive functions.31–33 In our study, Ber alleviated memory 
impairment in rats with epilepsy induced by Pilo. Ber had no 
effect on the memory function in non-SE control rats. This 
suggests that this dosage of Ber can suppress seizure activity 
while having no side effect of memory impairment. On the 
other hand, neuron loss is one of the mechanisms underlying 
cognitive impairment. Ber alleviated hippocampal neuronal 
degeneration, demonstrated by decreasing CA1 FJB-positive 
cells, in our study. It also performed a neuroprotective 
function in other central nervous system diseases. Besides, 
antioxidation, anti-inflammation, and antiapoptosis may be 
involved in this process.12,13,34 Additionally, Ber blocked the 
transient outward potassium current and delayed the recti-
fier potassium current in a concentration-dependent manner 
in acutely isolated CA1 pyramidal neurons.35 It is possible 
that a block of potassium currents is one of the mechanisms 
underlying its neuroprotective action.
In conclusion, the results of this study revealed that Ber 
exerts an anticonvulsant effect against Pilo-induced seizures 
in rats. Simultaneously, Ber attenuates memory impairment 
and neuronal degeneration in the hippocampus. At least in 
part, its beneficial effect is due to its potential to mitigate 
the oxidative stress burden. Therefore, this study further 
confirms the anticonvulsant activity of Ber, although more 
studies are necessary to elucidate the complete mechanism 
involved in these effects.
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